Abstract
The evolution of metastatic colorectal cancer in patients who have had surgical treatment for a primary lesion was studied in relation the progressive changes in the blood levels of carcinembryonic antigen (CEA), to gamma glutamyl transpeptidase (GGT) and routine liver function tests (LFTs). Involvement of the liver could ofter be reliably predicted many weeks in advance of clinical diagnosis while metastases to other sites were less likely to be detected early by this test. The association of the extent of disease with the patterns of biochemical changes is discussed with reference to several illustrative examples.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Cooper, E., Turner, R., Steele, L. et al. The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer. Br J Cancer 31, 111–117 (1975). https://doi.org/10.1038/bjc.1975.13
Issue Date:
DOI: https://doi.org/10.1038/bjc.1975.13
This article is cited by
-
A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinoma
Tumor Biology (2016)
-
Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma
Diseases of the Colon & Rectum (1991)
-
Colorectal cancer
Diseases of the Colon & Rectum (1988)
-
Quantitation and immunochemical characterization of carcinoembryonic antigen and glucose phosphate isomerase in blood and washings of patients with gastric and colonic diseases
The American Journal of Digestive Diseases (1978)
